latest news releases from the newsroom
Lone Star Steak House & Saloon
Lone Star Steakhouse & Saloon, Inc. Letter of Intent -- Disclosure of Buyer
WICHITA, Kan., April 5, 2002 (PRIMEZONE) -- The Company (Nasdaq:STAR) today confirmed that the unnamed prominent buyout firm with which it entered into a non-binding Letter of Intent is Bruckmann, Rosser, Sherrill & Co ("BRS"). The Company also confirmed that its Chief Executive Officer Jamie B. Coulter will not participate in the buyout. Hal Rosser, Managing Director of BRS stated, "We would have liked to work with Mr. Coulter. He is a talented manager who built a great company, but his intentions are to pursue other interests. If we reach a definitive agreement, and the transaction is approved by the Board of Directors and Lone Star's stockholders, Mr. Coulter has offered his support to us in a transitional role only for up to 90 days after the close of the transaction."
BOWE SYSTEC AG
BOWE SYSTEC AG Announces Date of 2002 Annual Results Press Briefing, Availability of Financial Calendar (with link)
FRANFURT AM MAIN, Germany, April 5, 2002 (PRIMEZONE) -- BOWE SYSTEC todaya announced: press briefing on annual results 2001 on April 8, 2002, in Munich; analyst's conference on April 9, 2002, in Frankfurt/Main; and analyst's conference on April 10, 2002, in London.
Women First HealthCare, Inc.
Women First HealthCare Emphasizes Managed Care Wins at Banc of America Securities Healthcare Conference
SAN DIEGO, April 5, 2002 (PRIMEZONE) -- Presenting at the Banc of America Securities Healthcare Conference in Las Vegas on Thursday, April 4, Women First HealthCare, Inc. (Nasdaq:WFHC) chairman, president and CEO Edward F. Calesa told attendees the Company has now secured three of the four largest Pharmacy Benefit Managers (PBMs) to support its lead product, Esclim(tm), a transdermal estrogen patch. Effective January 2002, AdvancePCS selected Esclim(tm) for its highest priority Performance Drug List. Effective March 2002, both Caremark Inc. and Express Scripts, Inc. selected Esclim(tm) in a preferred position. Collectively, this represents 150 million lives and $84 million in estimated total patch sales annually.